发明名称 DIAZENIUMDIOLATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHOD OF TREATING CANCER
摘要 Disclosed is a method of treating cancer in a patient comprising administering to the patient an effective amount of a diazeniumdiolated (N2O2-containing) compound or a pharmaceutically acceptable salt thereof, wherein the cancer cell has an elevated level of reactive oxygen species (ROS) and/or a decreased level of one or more of PRX1, PRX6, and OGG1, compared to a normal cell of the same tissue or tissue type. An example of a diazeniumdiolated compound is Formula (I), wherein X and Q are defined herein. Also disclosed are diazeniumdiolated compounds, pharmaceutical compositions, and methods of use including enhancing the chemotherapeutic treatment of chemotherapeutic agents and high energy radiation.
申请公布号 US2012238518(A1) 申请公布日期 2012.09.20
申请号 US201013509431 申请日期 2010.11.12
申请人 MACIAG ANNA E.;KEEFER LARRY K.;SAAVEDRA JOSEPH E.;ANDERSON LUCY M.;CHAKRAPANI HARINATH;THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT OF HEALTH AND HUMAN SERVICES 发明人 MACIAG ANNA E.;KEEFER LARRY K.;SAAVEDRA JOSEPH E.;ANDERSON LUCY M.;CHAKRAPANI HARINATH
分类号 A61K31/551;A61K31/495;A61K31/69;A61K31/704;A61P35/00;C07D243/08;C07D295/30 主分类号 A61K31/551
代理机构 代理人
主权项
地址